Ignite Creation Date:
2024-06-16 @ 11:49 AM
Last Modification Date:
2024-10-26 @ 3:31 PM
Study NCT ID:
NCT06439550
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-06-03
First Post:
2024-05-28
Brief Title:
Adjuvant Treatment With SerplulimabTrastuzumab and SOX in the HER-2 Positive GCGEJC
Sponsor:
The First Affiliated Hospital of Zhengzhou University
Organization:
The First Affiliated Hospital of Zhengzhou University
Conditions & Keywords Data
Conditions:
| Name |
|---|
| HER2-positive Gastric Cancer |
Keywords: